BackCitius Oncology Overview

Citius Oncology Inventory

Track Citius Oncology's inventory ($23M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$22.63M
↑ 31.48% YoYΔ $5.42M vs prior year quarter

Peer trimmed avg / median

Loading

Citius Oncology Inventory History

Loading

Citius Oncology vs. peers: Inventory Comparison

Loading

Citius Oncology Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Citius Oncology (CTOR) FAQ

As of the most recent data (June 2026), CTOR shows a inventory of $23M. That compares with $17M in the prior-year period — up 31.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CTOR's inventory is now $23M (was $17M) — a 31.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Citius Oncology is outperforming or lagging.

Tracking CTOR's inventory over time shows whether Citius Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $23M That compares with $17M in the prior-year period — up 31.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Citius Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $23M) with ownership activity and broader fundamentals.